Advertisement

Inpharma Weekly

, Volume 1636, Issue 1, pp 2–2 | Cite as

Sevelamer could be worth it in hyperphosphataemia

Clinical study
  • 4 Downloads

Keywords

Economic Evaluation Time Horizon Current Medical Dominant Strategy Absolute Threshold 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2008

Personalised recommendations